WO1995022346A1 - Use of ceruletide diethyl amine salt in the treatment of psoriasis - Google Patents
Use of ceruletide diethyl amine salt in the treatment of psoriasis Download PDFInfo
- Publication number
- WO1995022346A1 WO1995022346A1 PCT/IB1995/000282 IB9500282W WO9522346A1 WO 1995022346 A1 WO1995022346 A1 WO 1995022346A1 IB 9500282 W IB9500282 W IB 9500282W WO 9522346 A1 WO9522346 A1 WO 9522346A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- badges
- ceruletide
- psoriasis
- amine salt
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2207—Gastrins; Cholecystokinins [CCK]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Definitions
- the purpose of the present invention is the use of ceruletide diethyl amine salt (Takus) for the treatment of psoriasis.
- Ceruletide a well known decapeptide first extracted from the skin of Hyla caerulea, the Australian frog, and then prepared by synthesis, has the following formula:
- ceruletide diethyl amine salt administered by a single intramuscular injection in the dose from 2.5-5.0 ⁇ g, led to a significant improvement of the affection in all of the patients, with no exception, such an improvement lasting for 1-3 months.
- the sleep improvement, the stabilisation of the moral state and the decrease of the itch were noted in the first days next to the application.
- ceruletide diethyl amine salt Only one injection of ceruletide diethyl amine salt is normally sufficient for the treatment of psoriasis guttata.
- a second injection of the formulation administered as well in doses of 2.5-5.0 ⁇ g is needed, paying attention to the individual sensibility of the patient toward ceruletide diethyl amine salt, in the presence of particularly resistant badges.
- Diagnosis psoriasis nummularis, alcoholism.
- Anamnesis the first symptoms of psoriasis appeared after a car accident that happened when he was 15 years old.
- the badges on his forehead measured 2.5x3 and
- badges of psoriasis guttata and other badges As large as a coin on the whole back. 25 badges of psoriasis guttata and nummularis were on the lateral part of his left thigh. 32 purple badges, measuring 4.5x5.5 cm 2 at most, mostly covered with scales, were on the internal part of the thigh. 28 badges measuring from 0.5x0.5 cm 2 to 1.8x2.0 cm 2 were on his right thigh.
- a badge having a diameter of 5.0x6.0 cm 2 was noted on his front-upper left shin-bone, while the same zone of his right shin-bone was covered with 28 purple badges.
- the badges on the back went pale and semicircular, the ones on his legs reduced.
- the improvements of the skin disorder lasted for 3 months of the observation, when all of the badges disappeared: the positive effects being noticeable even after ten months.
- the patient started to drink alcohol again, from time to time, till, after the last drink, a relapse of psoriasis occurred, which was customarily treated in a specialised clinic with vitamins, quartz lamps and liniment for 41 days. 3 days after the discharge from the clinic the patient started to drink alcohol again and during the next week all of the symptoms of the disease reappeared. Comparing the two treatments effected, the one with ceruletide diethyl amine salt protracted his beneficial effects for a longer time.
- EXAMPLE 2 Patient N.I., woman, 35 years old, chronic gastritis
- Diagnosis psoriasis figurata and guttata, chronic gastritis.
- Anamnesis the first symptoms of psoriasis appeared after 2 months from an accident. The patient suffered from insomnia, amenorrhea and irritability. Some months after the accident some stains appeared on the contused part, and there were some stains on her chest and on her back. She was treated by vitamins, sedative drugs and tar ointment. The stains disappeared on the back and on the chest but reappeared on her face, arms and legs.
- the skin was depigmented in the places of the treated stains.
- the patient complains itch after bathing and badges on the knees, feet, abdomen and arms.
- the depigmented badges acquired the normal skin colour again and the improvement lasted in an irreversible way for about 4 months till the disappearing of all of the badges. No skin disorder of this patient was noted after such a period and during 10 months of the observation.
- EXAMPLE 3 patient CA. , man, 33 years old, single, engineer
- Diagnosis psoriasis seborrhoica, chronic pyelonephritis.
- the whole surface of the scalp was covered with the geriola form of psoriasis.
- the patient was treated with a single injection of 3.0 ⁇ g of ceruletide diethyl amine salt.
- the patient noted an improvement of the sleep and itch, and the stabilisation of the moral state.
- EXAMPLE 4 The patient S. Sh., 22 years old, single, university student, plays basketball and track-and-field sports.
- Diagnosis psoriasis guttata accompanied by gastritis.
- the patient cured himself with hormonal, salicylic and sulphurous ointments, vitamins, quartz and sun bathing.
- the badges went pale and disappeared leaving depigmented stains, yet they reappeared some weeks later.
- small badges On the face small badges mainly disposed along the hairline.
- small badges On the legs: small badges, disseminated on the back and on the side of tibiae and some badges on the knees.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7521701A JPH08509245A (en) | 1994-02-18 | 1995-02-13 | Use of ceruletide diethylamine salt in the treatment of psoriasis |
EP95914489A EP0696203A1 (en) | 1994-02-18 | 1995-02-13 | Use of ceruletide diethyl amine salt in the treatment of psoriasis |
MX9504335A MX9504335A (en) | 1994-02-18 | 1995-02-13 | Use of ceruletide diethyl amine salt in the treatment of psoriasis. |
AU21465/95A AU2146595A (en) | 1994-02-18 | 1995-02-13 | Use of ceruletide diethyl amine salt in the treatment of psoriasis |
NO954115A NO954115L (en) | 1994-02-18 | 1995-10-16 | Use of ceruletide-diethylamine salt in the treatment of psoriasis |
FI954912A FI954912A (en) | 1994-02-18 | 1995-10-16 | Use of ceruletide-ditylamine salt in the treatment of psoriasis |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI94A000298 | 1994-02-18 | ||
ITMI940298A IT1274015B (en) | 1994-02-18 | 1994-02-18 | USE OF CERULETIDE (TAKUS) IN THE TREATMENT OF PSORIASIS |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1995022346A1 true WO1995022346A1 (en) | 1995-08-24 |
Family
ID=11367909
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB1995/000282 WO1995022346A1 (en) | 1994-02-18 | 1995-02-13 | Use of ceruletide diethyl amine salt in the treatment of psoriasis |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP0696203A1 (en) |
JP (1) | JPH08509245A (en) |
AU (1) | AU2146595A (en) |
CA (1) | CA2160251A1 (en) |
FI (1) | FI954912A (en) |
HU (1) | HU9503295D0 (en) |
IL (1) | IL112578A0 (en) |
IT (1) | IT1274015B (en) |
MX (1) | MX9504335A (en) |
NO (1) | NO954115L (en) |
PL (1) | PL311159A1 (en) |
WO (1) | WO1995022346A1 (en) |
ZA (1) | ZA951137B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3034531A1 (en) * | 1980-09-12 | 1982-04-29 | Farmitalia Carlo Erba S.p.A., 20159 Milano | Analgesic use of tyrosine-O-sulphate poly:peptide cpds. - e.g. phyllo:caerulin and ceruletide in human and veterinary therapy |
GB2095992A (en) * | 1981-04-07 | 1982-10-13 | Shionogi Seiyaku Kk | Psycotropic drugs containing caerulein |
-
1994
- 1994-02-18 IT ITMI940298A patent/IT1274015B/en active IP Right Grant
-
1995
- 1995-02-08 IL IL11257895A patent/IL112578A0/en unknown
- 1995-02-13 PL PL95311159A patent/PL311159A1/en unknown
- 1995-02-13 CA CA002160251A patent/CA2160251A1/en not_active Abandoned
- 1995-02-13 AU AU21465/95A patent/AU2146595A/en not_active Abandoned
- 1995-02-13 WO PCT/IB1995/000282 patent/WO1995022346A1/en not_active Application Discontinuation
- 1995-02-13 EP EP95914489A patent/EP0696203A1/en not_active Withdrawn
- 1995-02-13 JP JP7521701A patent/JPH08509245A/en active Pending
- 1995-02-13 ZA ZA951137A patent/ZA951137B/en unknown
- 1995-02-13 HU HU9503295A patent/HU9503295D0/en unknown
- 1995-02-13 MX MX9504335A patent/MX9504335A/en unknown
- 1995-10-16 NO NO954115A patent/NO954115L/en unknown
- 1995-10-16 FI FI954912A patent/FI954912A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3034531A1 (en) * | 1980-09-12 | 1982-04-29 | Farmitalia Carlo Erba S.p.A., 20159 Milano | Analgesic use of tyrosine-O-sulphate poly:peptide cpds. - e.g. phyllo:caerulin and ceruletide in human and veterinary therapy |
GB2095992A (en) * | 1981-04-07 | 1982-10-13 | Shionogi Seiyaku Kk | Psycotropic drugs containing caerulein |
Non-Patent Citations (2)
Title |
---|
DATABASE MEDLINE FILE SERVER STN KARLSRUHE; WALDMANN ET AL: "CONSERVATIVE TREATMENT OF SEVERE PARALYTIC ILEUS.CLINICAL EXPERIENCES WITH CERULETID" * |
ED:BUDAVARI: "THE MERCK INDEX.ELEVENTH EDITION", MERCK & CO.,INC., RAHWAY,N.J.,USA * |
Also Published As
Publication number | Publication date |
---|---|
CA2160251A1 (en) | 1995-08-24 |
IT1274015B (en) | 1997-07-14 |
FI954912A0 (en) | 1995-10-16 |
ITMI940298A0 (en) | 1994-02-18 |
FI954912A (en) | 1995-10-16 |
NO954115D0 (en) | 1995-10-16 |
JPH08509245A (en) | 1996-10-01 |
ITMI940298A1 (en) | 1995-08-19 |
AU2146595A (en) | 1995-09-04 |
EP0696203A1 (en) | 1996-02-14 |
MX9504335A (en) | 1997-05-31 |
HU9503295D0 (en) | 1996-01-29 |
NO954115L (en) | 1995-10-16 |
PL311159A1 (en) | 1996-02-05 |
ZA951137B (en) | 1995-12-01 |
IL112578A0 (en) | 1995-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jiang et al. | Auricular vagus nerve stimulation promotes functional recovery and enhances the post-ischemic angiogenic response in an ischemia/reperfusion rat model | |
Hamm | Testosterone propionate in the treatment of angina pectoris | |
CA2643205A1 (en) | Agent for correcting stress-inducing neuro-mediator, neuro- endocrine and metabolic disturbances and method for preventing and treating concomitant pathological conditions | |
JP2020019790A (en) | Methods for treating prader-willi syndrome | |
JP2019537628A (en) | Combination therapy | |
JP2001527537A (en) | Use of a substance having oxytocin activity for the manufacture of a medicament for the treatment of affective pain syndrome | |
Ahmed et al. | Efficacy of clarithromycin in pityriasis rosea | |
US5378686A (en) | Therapeutic treatment of fibromyalgia | |
Taira et al. | Antioxidative effects of a novel dietary supplement Neumentix in a mouse stroke model | |
BR112020006246A2 (en) | METHOD FOR WEIGHT CONTROL OF A SUBJECT IN NEED | |
EP0696203A1 (en) | Use of ceruletide diethyl amine salt in the treatment of psoriasis | |
Kauli et al. | THE LH RESPONSE TO LH‐RELEASING HORMONE IN CHILDREN WITH TRUE ISOSEXUAL PRECOCIOUS PUBERTY TREATED WITH CYPROTERONE ACETATE | |
Reinhold et al. | THE EFFECTS OF GLYCINE (GLYCOCOLL) IN MUSCULAR DYSTROPHY: WITH ESPECIAL REFERENCE TO CHANGES IN STRUCTURE AND COMPOSITION OF VOLUNTARY MUSCLE | |
Kadlubowska et al. | Systemic contact dermatitis caused by inhaled cashew oil smoke. | |
Jungkunz et al. | Acute effects of the synthetic analogue of methionine enkephalin FK 33-824 on depressive symptoms | |
AU611961B2 (en) | Pharmaceutical preparation for curing multiple sclerosis and lateral amyotrophic sclerosis | |
Mazal | Transient ischaemic attacks and increased platelet aggregability associated with oral contraceptives. Treatment with dipyridamole and aspirin. | |
Smith | Tongue Changes in British Troops | |
RU2119350C1 (en) | Agent for treatment of patients with psoriasis | |
SU1667865A1 (en) | Method for treatment and prophylaxis of postcalving hydrocalciemia in cows | |
Sterk | Alopecia Areata-Current and Emerging Therapies | |
Song et al. | Sarcopenia and Sarcopenic Obesity–A Brief Review | |
US10279004B2 (en) | Methods and compositions for enhancing or maintaining fertility | |
JP2024506953A (en) | PLAQUE Improvement effect of Tapinarov in the treatment of psoriasis, atopic dermatitis, and radiation dermatitis | |
Bishop et al. | Behavioral toxicity associated with benzquinamide (Quantril) therapy in schizophrenic patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NL NO NZ PL PT RO RU SD SE SI SK TJ TT UA US UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 1995 530239 Country of ref document: US Date of ref document: 19951010 Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2160251 Country of ref document: CA Ref document number: 283429 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 954912 Country of ref document: FI |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1995914489 Country of ref document: EP |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 1995914489 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1995914489 Country of ref document: EP |